LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,276,011 | -22.8% | 71,362 | -7.1% | 0.01% | -12.5% |
| Q2 2023 | $5,539,587 | +383.6% | 76,832 | +393.4% | 0.01% | +300.0% |
| Q1 2023 | $1,145,403 | -6.4% | 15,571 | -15.0% | 0.00% | 0.0% |
| Q4 2022 | $1,223,843 | -12.9% | 18,321 | +12.3% | 0.00% | 0.0% |
| Q3 2022 | $1,405,000 | -8.0% | 16,321 | -4.7% | 0.00% | 0.0% |
| Q2 2022 | $1,528,000 | -21.9% | 17,126 | -1.5% | 0.00% | -33.3% |
| Q1 2022 | $1,956,000 | -29.8% | 17,395 | -1.6% | 0.00% | 0.0% |
| Q4 2021 | $2,785,000 | +6.8% | 17,685 | -1.9% | 0.00% | -25.0% |
| Q3 2021 | $2,608,000 | +66.2% | 18,025 | +50.7% | 0.00% | +100.0% |
| Q2 2021 | $1,569,000 | -59.4% | 11,957 | -52.8% | 0.00% | -66.7% |
| Q1 2021 | $3,865,000 | -60.5% | 25,354 | -74.3% | 0.01% | -62.5% |
| Q4 2020 | $9,795,000 | +8.5% | 98,502 | +4.0% | 0.02% | -5.9% |
| Q3 2020 | $9,026,000 | +80.6% | 94,698 | +111.9% | 0.02% | +70.0% |
| Q2 2020 | $4,999,000 | +440.4% | 44,695 | +251.3% | 0.01% | +400.0% |
| Q1 2020 | $925,000 | -35.9% | 12,724 | -8.0% | 0.00% | 0.0% |
| Q4 2019 | $1,443,000 | -26.9% | 13,837 | -30.2% | 0.00% | -33.3% |
| Q3 2019 | $1,974,000 | -15.2% | 19,826 | -2.8% | 0.00% | -25.0% |
| Q2 2019 | $2,327,000 | -11.3% | 20,388 | -2.3% | 0.00% | 0.0% |
| Q1 2019 | $2,624,000 | -9.8% | 20,877 | -2.6% | 0.00% | -20.0% |
| Q4 2018 | $2,908,000 | -90.1% | 21,424 | -80.0% | 0.01% | -88.4% |
| Q3 2018 | $29,336,000 | +79.4% | 106,876 | +35.4% | 0.04% | +79.2% |
| Q2 2018 | $16,349,000 | +27.5% | 78,916 | +1.6% | 0.02% | +20.0% |
| Q1 2018 | $12,825,000 | +18.7% | 77,650 | -1.6% | 0.02% | +33.3% |
| Q4 2017 | $10,802,000 | +10.0% | 78,885 | +9.3% | 0.02% | +7.1% |
| Q3 2017 | $9,823,000 | +66.8% | 72,150 | +48.7% | 0.01% | +55.6% |
| Q2 2017 | $5,889,000 | -6.7% | 48,507 | -18.7% | 0.01% | -10.0% |
| Q1 2017 | $6,315,000 | -6.9% | 59,665 | -10.6% | 0.01% | -9.1% |
| Q4 2016 | $6,782,000 | -9.5% | 66,748 | -9.1% | 0.01% | -8.3% |
| Q3 2016 | $7,496,000 | -33.1% | 73,450 | -21.8% | 0.01% | -36.8% |
| Q2 2016 | $11,199,000 | +19.9% | 93,900 | +7.7% | 0.02% | +11.8% |
| Q1 2016 | $9,338,000 | +2.0% | 87,197 | +3.3% | 0.02% | 0.0% |
| Q4 2015 | $9,154,000 | +13.5% | 84,432 | -10.3% | 0.02% | +6.2% |
| Q3 2015 | $8,065,000 | -20.9% | 94,162 | -6.8% | 0.02% | -11.1% |
| Q2 2015 | $10,194,000 | +9.5% | 101,032 | -16.3% | 0.02% | +12.5% |
| Q1 2015 | $9,307,000 | -10.3% | 120,692 | -38.1% | 0.02% | -15.8% |
| Q4 2014 | $10,379,000 | -17.0% | 195,052 | -26.7% | 0.02% | -20.8% |
| Q3 2014 | $12,511,000 | -16.7% | 266,252 | +10.4% | 0.02% | -7.7% |
| Q2 2014 | $15,017,000 | -3.5% | 241,076 | +4.2% | 0.03% | -10.3% |
| Q1 2014 | $15,555,000 | +10.7% | 231,262 | -13.4% | 0.03% | +3.6% |
| Q4 2013 | $14,053,000 | +81.1% | 267,162 | +49.0% | 0.03% | +75.0% |
| Q3 2013 | $7,760,000 | +48.1% | 179,302 | +28.1% | 0.02% | +33.3% |
| Q2 2013 | $5,239,000 | – | 140,002 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |